Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEResultResults5 Aug 2026

eClerx Services Ltd

Earnings Presentation and Press Release w.r.t Consolidated and Standalone Un-Audited Financial Results for the Quarter/Period ended June 30, 2026.

eClerx Services Ltd reported its Q1 FY27 earnings, with a 15.2% YoY growth in OPG revenue and a 23.8% YoY growth in total revenue. The company's EBITDA margin decreased by 330 bps YoY, and the PAT margin decreased by 264 bps YoY. eClerx proposed a dividend of INR 1 for FY27. The company's wage increments were effective from April 1, 2026. eClerx's revenue by industry showed BFSI at 41.8%, CMT at 26.4%, HiTech and M&D at 16.8%, Fashion and Luxury at 21.4%, and Emerging at 4.7%. The company's ACV of new deals was $137.4 MM in Q1 FY27. eClerx's hedge updates showed a current total outstanding hedge of $273.6 MM at an average INR 93.41/$.

Read more →📎 1 attachment
NSEPress ReleaseResults5 Aug 2026

FDC Limited

Press Release

FDC Limited has announced its unaudited financial results for the first quarter ended June 30, 2026, with revenue from operations increasing by 3.0% YoY to Rs. 668 crores, and profit after tax increasing by 9.2% YoY to Rs. 132 crores.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults5 Aug 2026

DCW Limited

Analysts/Institutional Investor Meet/Con. Call Updates

DCW Limited has informed the Exchange about the proposed schedule of an earnings conference call for investors and analysts to discuss the unaudited financial results for Q1-FY27. The call is scheduled for August 14, 2026, at 02:00 P.M. (IST).

Read more →📎 1 attachment
NSEInvestor PresentationResults5 Aug 2026

Cohance Lifesciences Limited

Investor Presentation

Cohance Lifesciences Limited has informed the Exchange about Investor Presentation, which includes unaudited financial results for Q1 FY2027. The company's revenue declined 23.1% YoY, and EBITDA declined 2.2% YoY. The management has acted on two immediate priorities—building an integrated nucleic-acid business and repositioning Agrochemicals towards a broader innovator-product-led portfolio. The company expects sequential improvement from Q2 and growth to return during H2 FY27.

Read more →📎 1 attachment
NSEGeneral UpdatesResults5 Aug 2026

BlueStone Jewellery and Lifestyle Limited

General Updates

BlueStone Jewellery and Lifestyle Limited has allotted 342766 equity shares under the Employee Stock Option Plan 2014 to eligible employees, increasing the issued, subscribed and paid-up equity share capital from ₹ 15,24,06,634 to ₹ 15,27,49,400.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults5 Aug 2026

PB Fintech Limited

Outcome of Board Meeting

PB Fintech Limited has announced its Q1FY27 results, with a 41% YoY growth in total insurance premium to ₹8,372 Cr, led by a 53% YoY growth in new protection premium. The company's PAT grew 92% YoY to ₹163 Cr, with a PAT margin of 9%. The company has also reconstituted its Corporate Social Responsibility Committee and Stakeholders Relationship Committee.

Read more →📎 1 attachment
BSEResultResults5 Aug 2026

Datamatics Global Services Ltd

As attached

Datamatics Global Services Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results at their meeting held on August 5, 2026.

Read more →📎 1 attachment
NSEPress ReleaseResults5 Aug 2026

eClerx Services Limited

Press Release

eClerx Services Limited has announced its Q1 FY27 financial results, with revenue growth of 15.2% YoY and 2.8% QoQ, and EBITDA growth of 18.4% YoY and -6.6% QoQ. The company has proposed a dividend of INR 1 for FY27.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults5 Aug 2026

eClerx Services Limited

Investor Presentation

eClerx Services Limited has announced its Q1 FY27 earnings, with a revenue growth of 15.2% YoY and 2.8% QoQ. The company has proposed a dividend of INR 1 for FY27. The earnings presentation and press release are available on the company's website.

Read more →📎 1 attachment
NSEPress ReleaseResults5 Aug 2026

Cohance Lifesciences Limited

Press Release

Cohance Lifesciences Limited has announced its unaudited financial results for the first quarter ended June 30, 2026, with revenue from operations of ₹4,223 million, down 23.1% year-on-year, and adjusted EBITDA of ₹92 million. The company has guided for a strong growth rebound in the second half of the year, supported by secured orders, scheduled deliveries, and progress across its late-stage pipeline.

Read more →📎 1 attachment
← PreviousPage 1230 of 2151Next →